Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy

Benjamin D. Horne, Petra A. Lenzini, Mia Wadelius, Andrea L. Jorgensen, Stephen E. Kimmel, Paul M. Ridker, Niclas Eriksson, Jeffrey L. Anderson, Munir Pirmohamed, Nita A. Limdi, Robert C. Pendleton, Gwendolyn A. Mcmillin, James K. Burmester, Daniel Kurnik, C. Michael Stein, Michael D. Caldwell, Charles S. Eby, Anders Rane, Jonatan D. Lindh, Jae Gook ShinHo Sook Kim, Pantep Angchaisuksiri, Robert J. Glynn, Kathryn E. Kronquist, John F. Carlquist, Gloria R. Grice, Robert L. Barrack, Juan Li, Brian F. Gage

Research output: Contribution to journal › Article › peer-review

63 Scopus citations

Fingerprint

Dive into the research topics of 'Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science